Antibiotic shortage to continue

Bicillin L-A supply shortages set to continue, manufacturer warns Pfizer Australia has advised the Therapeutic Goods Administration (TGA) that stocks of its Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringes for injection (600,000 units per syringe and 1.2 million units per syringe) will remain in short supply until “mid-2024”.  Having previously approved the issued approval for the importation of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Board issues identity theft warning